Rhythm Pharmaceuticals Inc (RYTM)
52.98
+3.98
(+8.11%)
USD |
NASDAQ |
Nov 04, 16:00
52.98
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Market Cap: 3.239B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.996B |
| October 31, 2024 | 2.918B |
| October 30, 2024 | 3.029B |
| October 29, 2024 | 3.029B |
| October 28, 2024 | 3.022B |
| October 25, 2024 | 2.968B |
| October 24, 2024 | 3.039B |
| October 23, 2024 | 2.997B |
| October 22, 2024 | 3.004B |
| October 21, 2024 | 3.068B |
| October 18, 2024 | 3.109B |
| October 17, 2024 | 3.120B |
| October 16, 2024 | 3.199B |
| October 15, 2024 | 3.082B |
| October 14, 2024 | 3.071B |
| October 11, 2024 | 3.046B |
| October 10, 2024 | 2.933B |
| October 09, 2024 | 2.917B |
| October 08, 2024 | 2.940B |
| October 07, 2024 | 2.886B |
| October 04, 2024 | 3.034B |
| October 03, 2024 | 2.970B |
| October 02, 2024 | 3.118B |
| October 01, 2024 | 3.165B |
| September 30, 2024 | 3.203B |
| Date | Value |
|---|---|
| September 27, 2024 | 3.139B |
| September 26, 2024 | 3.126B |
| September 25, 2024 | 3.194B |
| September 24, 2024 | 3.132B |
| September 23, 2024 | 3.121B |
| September 20, 2024 | 3.228B |
| September 19, 2024 | 3.335B |
| September 18, 2024 | 3.279B |
| September 17, 2024 | 3.250B |
| September 16, 2024 | 3.027B |
| September 13, 2024 | 3.033B |
| September 12, 2024 | 3.015B |
| September 11, 2024 | 3.015B |
| September 10, 2024 | 3.001B |
| September 09, 2024 | 3.097B |
| September 06, 2024 | 3.011B |
| September 05, 2024 | 2.951B |
| September 04, 2024 | 2.867B |
| September 03, 2024 | 2.809B |
| August 30, 2024 | 2.891B |
| August 29, 2024 | 2.818B |
| August 28, 2024 | 2.836B |
| August 27, 2024 | 2.900B |
| August 26, 2024 | 3.057B |
| August 23, 2024 | 2.819B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
157.23M
Minimum
May 19 2022
3.335B
Maximum
Sep 19 2024
1.302B
Average
1.062B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 765.37B |
| TG Therapeutics Inc | 3.792B |
| Regeneron Pharmaceuticals Inc | 91.08B |
| Mirum Pharmaceuticals Inc | 1.931B |
| Moderna Inc | 20.59B |
Market Cap Related Metrics
| PS Ratio | 31.01 |
| PEG Ratio | -0.3691 |
| Price to Book Value | 82.33 |
| Price | 52.98 |
| Earnings Yield | -8.23% |
| PEGY Ratio | -0.3691 |